Geert R. Kersten
Net Worth

Last updated:

What is Geert R. Kersten net worth?

The estimated net worth of Mr. Geert R. Kersten is at least $25,179,817 as of 8 May 2024. He owns shares worth $10,315,517 as insider and has received compensation worth at least $14,864,300 in CEL-SCI Corporation.

What is the salary of Geert R. Kersten?

Mr. Geert R. Kersten salary is $675,650 per year as Chief Executive Officer, Principal Accounting & Financial Officer, Treasurer and Director in CEL-SCI Corporation.

How old is Geert R. Kersten?

Mr. Geert R. Kersten is 66 years old, born in 1959.

What stocks does Geert R. Kersten currently own?

As insider, Mr. Geert R. Kersten owns shares in one company:

Company Title Shares Price per share Total value
CEL-SCI Corporation (CVM) Chief Executive Officer, Principal Accounting & Financial Officer, Treasurer and Director 1,195,309 $8.63 $10,315,517

What does CEL-SCI Corporation do?

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

CVM logo
CVM
CEL-SCI Corporation
$8.63

Geert R. Kersten insider trading

CEL-SCI Corporation

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 30,000 $1.39 $41,700
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 4,617 $10.83 $50,002
Purchase
Common Stock 6,631 $7.54 $49,998
Purchase
Common Stock 3,725 N/A N/A
Purchase
Series S Warrants 69,000 $1.25 $86,250
Purchase
Common Stock 14,999 $0.77 $11,549
Purchase
Series S Warrants 170,000 $1.25 $212,500
Purchase
Series S Warrants 100,000 $1.25 $125,000
Purchase
Series S Warrants 30,000 $1.25 $37,500
Purchase
Common Stock 300,000 $0.6 $180,000
Purchase
Common Stock 8,400 $0.79 $6,636
Purchase
Common Stock 145,120 $0.24 $34,829
Purchase
Common Stock 40,000 $0.25 $10,000
Purchase
Common Stock 118,700 $0.27 $31,456
Purchase
Common Stock 348,125 $0.21 $74,499
Purchase
Common Stock 348,125 $0.21 $74,499
Purchase
Common Stock 7,400 $0.61 $4,514
Purchase
Common Stock 4,800 $0.66 $3,163
Purchase
Common Stock 8,500 $0.45 $3,825
Purchase
Common Stock 10,500 $0.63 $6,615
Purchase
Common Stock 3,800 $0.84 $3,173
Purchase
Common Stock 4,600 $0.67 $3,082
Purchase
Common Stock 7,800 $0.56 $4,368
Purchase
Common Stock 52,136 $0.58 $30,239
Purchase
Common Stock 4,800 $0.67 $3,216
Purchase
Common Stock 22,500 $0.77 $17,325
Purchase
Common Stock 65,100 $0.76 $49,476
Purchase
Common Stock 65,100 $0.76 $49,476
Purchase
Common Stock 73,100 $0.68 $49,635
Purchase
Common Stock 10,500 $0.74 $7,770
Purchase
Common Stock 72,500 $0.54 $39,440
Purchase
Common Stock 56,700 $0.54 $30,845
Purchase
Common Stock 4,063 $0.74 $3,007
Purchase
Common Stock 2,230 $1.13 $2,520
Purchase
Common Stock 3,201 $1.05 $3,361

CEL-SCI key executives

CEL-SCI Corporation executives and other stock owners filed with the SEC: